Industry Trends

North America 2,5-Dimethyl-2,4-Hexadiene Market size surpassed USD 52.7 thousand in 2019 and is estimated to witness over 2.7% CAGR between 2020 and 2026. Accelerating demand for insecticides and potential usage of the product in healthcare applications will drive the market size.

Get more details on this report - Request Free Sample PDF

2,5-Dimethyl-2,4-hexadiene is one of key intermediates for the synthesis of esters of chrysanthemic acids. The end products are widely used in domestic hygiene and agriculture owing to lesser toxicity and enhanced efficiency of products. The prins condensation of isobutylene with isobutyl aldehyde is considered as one of the valuable & economic ways for the synthesis of 2,5-dimethyl-2,4-hexadiene.

The growing demand for 2,5-dimethyl-2,4-hexadiene compound in the crop protection sector will provide a positive scope for the 2,5-dimethyl-2,4-hexadiene industry expansion. The increasing focus on improving the crop output due to the growing food demand and limited arable lands led to a rise in the usage of insecticides. Further, ongoing developments in the agricultural sector along with a growing concern over the usage of toxic compounds in the agricultural sector are expected to drive the product demand.

However, the COVID-19 pandemic has highly impacted various industries including the pesticide industry, which has witnessed a significant drop in the revenue. It can be majorly attributed to the decline in production in the U.S. and other countries. The COVID-19 pandemic has caused disruption in supply chains, shortage of materials, and termination of contracts to control expenses. Moreover, the lack of labor is also hampered the overall product demand for the FY2020.

North American Market, By Application

Get more details on this report - Request Free Sample PDF

Insecticides is the major application segment, accounting for over 56% of the North America 2,5-dimethyl-2,4-hexadiene market share in 2019. The growing demand for insecticides coupled with a rising requirement to enhance crop production output is driving the usage of the compound across the globe. Pyrethroids are a synthetic analogy of pyrethrin and possess lower toxicity compared to several other insecticides & pesticides. The growing production of corn, cotton, and soybeans in the U.S. is likely to boost the demand for pesticides, propelling the adoption of 2,5-dimethyl-2,4-hexadiene.

2,5-Dimethyl-2,4-hexadiene is potentially used as a biomarker in the identification of lung cancer. North America consists one of the largest cancer population. According to the National Cancer Institute, there were approximately 16.9 million cancer survivors in the United States in 2019. However, this number is projected to reach 22.2 million by 2030. Based on the data retrived from cancer patients between 2015 and 2017, some 39.5% of men and women will be diagnosed with cancer at some point in their life. As of now, approximately 541,000 americans are probably suffering from lung cancer. In 2018, 234,030 americans were estimated to be diagnosed with lung cancer representing around 13% of all cancer discovery in the country. Moroever, America Cancer society estimates that 1,898,160 new cancer pateints and 608,570 cancer deaths are likely to happen in the United States in 2021.

Furthermore, 2,5-dimethyl-2,4-hexadiene is heavily used in the production of 9-chloroanthracene that finds application as a key intermediate for numerous harmaceutical rections. The pharmaceutica industry in the North America is highly organized. The U.S. is a dominating natio in the pharma market and drives the drug development and demand. Infact many of the top pharmaceutical technology companies are headquartered in the country. The key players are heavily investing in research & development to develop novel anticancer agents, which is a key factor fueling the consumption of 9-chloroanthracene.

Competitive Industry Landscape

Major manufacturers are investing in R&D to learn novel techniques for the synthesis of 2,5-dimethyl-2,4-hexadiene. The key industry players include Tokyo Chemical Industry Co., Ltd. (TCI), Sigma-Aldrich Co., Santa Cruz Biotechnology, Inc., BeanTown Chemical, Alfa Aesar, Matrix Scientific, and Toronto Research Chemical.

These participants are engaged in the strategic initiatives, such mergers, geoggrapgical expansions, production capacity extension, and acquisition, among others to reinforce their market dominance. For instance, in December 2020, Merk Group announced its plan to expand the production capacities of its life science business segment in the U.S. with an investment of around USD 48.7 million. The company expanded its production capacity of two production facilities situated in Danvers and Jaffrey by end of FY 2021. This strategy will enable the company to expand its production foothold in life science business across the U.S.